BioSynBoros, Inc.
Our aim is to create a new paradigm of proactive risk resilience against addictive use disorders- bridging the gap between decades of research data and real-world application to address addiction prior to onset.
To address this protracted inaction, BioSynBoros, Inc. has formulated intervention protocols---We are excited and proud to introduce:
The Connectome Project
patent pending
100% Non-Invasive, Holistic and Fully-Remote Collection Models
Comprehensive whole-system frameworks to create personalized susceptibility scores and optimize risk resilience during adolescents against addiction and alcoholism using preventive therapeutic stratifications from molecular pathogenicity derived data.
and
The M.U.L.L.I.G.A.N. System
patent pending
When conventional systems fail, the MULLIGAN Tranq-Dope reversal system with formulary ingredients which reverse poly-drug overdose effects from Xylazine and Metatomadine while also having exhibiting potential for treatment of drug induced wound necrosis.
We invite interested parties, collaborators and investors to email kari@biosynboros.com
Integrative Precision Data Driving Personalized Care
Innovative Algorithmic Solutions for SUD Risk Resilience
Harnessing Data to Address Complex Biological and Environmental Factors via Personalized Holistic Intervention Guidance
BioSynBoros synthesizes multi-modal data sources—genetic, metabolic, enzymatic, hormonal, and behavioral—to deliver precise risk resilience profiles for alcohol and substance use disorders prior to ingestion. Our platform supports youth and adolescent individuals via fully remote, non-invasive specimen collection and repeat testing to empower ongoing resilience management and guidance. Let's protect our future generations from the scourge of addiction.
Why Support BioSynBoros, Inc. ?
Cutting-edge technology combining human compassion, non-clinical entities, data-banked results from decades of research--we bridge the data to real-world applications--helping underserved and vulnerable populations enjoy real solutions for the decades of disease dissection they have undergone without relief.
Multimodal Diagnostic Platform
Combines proteomic, genetic, metabolic, and neurophysiological markers for comprehensive risk resilience assessment.
Machine Learning Analytics
Advanced ML algorithms analyze aggregated complex datasets to generate personalized risk resilience scores.
Remote Specimen Collection
Completely non-invasive and remote proprietary stabilized specimen kits enable convenient, accurate sample collection from home.
Personalized Therapeutic Stratification
Tailored holistic intervention guidance based on whole system resilience profiles. Followed up using further specimen data for longitudinal assurance that whole-systems molecular balance is being restored and maintained.
Get in touch
E-mail: neurohealix@gmail.com / kari@biosynboros.com
Address: Westmoreland county, Pennsylvania, USA